133 related articles for article (PubMed ID: 33415524)
1. Do epoch lengths of hypnotic depth indicators affect estimated of blood-brain equilibration rate constants of propofol?
Kim KM; Park S; Kang BJ; Choi BM; Noh GJ; Bang JY
J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):305-317. PubMed ID: 33415524
[TBL] [Abstract][Full Text] [Related]
2. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
3. Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.
Dahaba AA; Xiao Z; Zhu X; Dong H; Xiong L; Rehak P; Zelzer S; Wang K; Reibnegger G
J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):145-161. PubMed ID: 32100175
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of unconsciousness prediction probability with approximate entropy and bispectral index during sedation].
Ouyang MW; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):287-9. PubMed ID: 16546728
[TBL] [Abstract][Full Text] [Related]
5. Bispectral index dynamics during propofol hypnosis is similar in red-haired and dark-haired subjects.
Doufas AG; Orhan-Sungur M; Komatsu R; Lauber R; Akca O; Shafer SL; Sessler DI
Anesth Analg; 2013 Feb; 116(2):319-26. PubMed ID: 23302977
[TBL] [Abstract][Full Text] [Related]
6. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index.
Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH
Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103
[TBL] [Abstract][Full Text] [Related]
7. Induction speed is not a determinant of propofol pharmacodynamics.
Doufas AG; Bakhshandeh M; Bjorksten AR; Shafer SL; Sessler DI
Anesthesiology; 2004 Nov; 101(5):1112-21. PubMed ID: 15505446
[TBL] [Abstract][Full Text] [Related]
8. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM
Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
[TBL] [Abstract][Full Text] [Related]
9. Wide inter-individual variability of bispectral index and spectral entropy at loss of consciousness during increasing concentrations of dexmedetomidine, propofol, and sevoflurane.
Kaskinoro K; Maksimow A; Långsjö J; Aantaa R; Jääskeläinen S; Kaisti K; Särkelä M; Scheinin H
Br J Anaesth; 2011 Oct; 107(4):573-80. PubMed ID: 21733891
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.
Lee SH; Ghim JL; Song MH; Choi HG; Choi BM; Lee HM; Lee EK; Roh YJ; Noh GJ
Br J Pharmacol; 2009 Dec; 158(8):1982-95. PubMed ID: 19925493
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.
Muñoz HR; Cortínez LI; Ibacache ME; Altermatt FR
Anesthesiology; 2004 Dec; 101(6):1269-74. PubMed ID: 15564932
[TBL] [Abstract][Full Text] [Related]
12. Relationship between bispectral index, electroencephalographic state entropy and effect-site EC50 for propofol at different clinical endpoints.
Iannuzzi M; Iannuzzi E; Rossi F; Berrino L; Chiefari M
Br J Anaesth; 2005 May; 94(5):613-6. PubMed ID: 15734785
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Bispectral Index, electroencephalographic state entropy and effect-site EC50 for propofol at different clinical endpoints.
Iannuzzi M; Iannuzzi E; Rossi F; Berrino L; Chiefari M
Br J Anaesth; 2005 Apr; 94(4):492-5. PubMed ID: 15665070
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints.
Blussé van Oud-Alblas HJ; Brill MJE; Peeters MYM; Tibboel D; Danhof M; Knibbe CAJ
BMC Anesthesiol; 2019 Jan; 19(1):15. PubMed ID: 30669968
[TBL] [Abstract][Full Text] [Related]
15. Estimating the plasma effect-site equilibrium rate constant (Ke₀) of propofol by fitting time of loss and recovery of consciousness.
Wu Q; Sun B; Wang S; Zhao L; Qi F
Biol Pharm Bull; 2013; 36(9):1420-7. PubMed ID: 23803230
[TBL] [Abstract][Full Text] [Related]
16. A Recirculatory Model for Pharmacokinetics and the Effects on Bispectral Index After Intravenous Infusion of the Sedative and Anesthetic AZD3043 in Healthy Volunteers.
Björnsson MA; Norberg Å; Kalman S; Simonsson USH
Anesth Analg; 2015 Oct; 121(4):904-913. PubMed ID: 26097984
[TBL] [Abstract][Full Text] [Related]
17. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
[TBL] [Abstract][Full Text] [Related]
18. The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusion.
Glen JB; Engbers FH
Anaesthesia; 2016 Mar; 71(3):306-14. PubMed ID: 26682512
[TBL] [Abstract][Full Text] [Related]
19. Predictive ability of propofol effect-site concentrations during fast and slow infusion rates.
Sepúlveda PO; Cortínez LI; Recart A; Muñoz HR
Acta Anaesthesiol Scand; 2010 Apr; 54(4):447-52. PubMed ID: 20003124
[TBL] [Abstract][Full Text] [Related]
20. Bispectral and spectral entropy indices at propofol-induced loss of consciousness in young and elderly patients.
Lysakowski C; Elia N; Czarnetzki C; Dumont L; Haller G; Combescure C; Tramèr MR
Br J Anaesth; 2009 Sep; 103(3):387-93. PubMed ID: 19542103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
